Regorafenib and sunitinib for treating advanced gastrointestinal stromal tumours

Published on 04 Jan 2022
Last Updated on 02 Jan 2024

Regorafenib and sunitinib for treating advanced gastrointestinal stromal tumours Guidance is outdated and has been withdrawn on 2 Jan 2024. 

The Plain English Summary (PES) has been updated on 2 Jan 2024.

Regorafenib and sunitinib for treating advanced GISTs (Withdrawn 2 Jan 2024) [PDF, 160 KB]

PES Regorafenib and sunitinib for advanced GISTs (Updated 2 Jan 2024) [PDF, 85 KB]